Indefinite Delivery Contract SPE2DU25D9163

The awarded federal contract IDV is a single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The prime contractor, DMS Pharmaceutical Group Inc., is a woman-owned small business pharmaceutical wholesaler based in Illinois that specializes in providing a comprehensive range of pharmaceutical products and medical supplies to federal government agencies, particularly the Department of Defense (DoD).

The IDC enables the DLA to issue firm fixed-price delivery orders for a wide portfolio of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract covers various product categories such as injections, tablets, creams, auto-injectors, and specialty medications, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain and providing direct distribution of prescription drugs and pharmacy services to DoD healthcare sites. This contract is not associated with any set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains.